The impact of the consistency evaluation policy of generic drugs on the integration of innovation chain and industrial chain in the pharmaceutical manufacturing industry. [PDF]
Front Public HealthXie Y, Zhang W.
europepmc +1 more source
Strategic resource allocation: an agent-based model of ambidextrous strategies in the pharmaceutical industry. [PDF]
Cost Eff Resour AllocPourzia S, Hajipour B.
europepmc +1 more source
Access in all areas? A round-up of developments in market access and health technology assessment: part 13. [PDF]
J Comp Eff ResRamagopalan SV, Pannelay AJ.
europepmc +1 more source
The registration status of maternal, newborn, and child health medical products: evidence from 9 countries. [PDF]
J Pharm Policy PractBriggs J +13 more
europepmc +1 more source
Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety. [PDF]
Ther Adv Drug Saf, 2015 Ruan X, Kaye AD.
europepmc +1 more source
Determination of 5-Hydroxymethylfurfural Content in Marketed Honey: A Modified RP-HPLC Method. [PDF]
Int J Anal ChemAdu-Brimpong B +5 more
europepmc +1 more source
Global Pharmaceutical Regulation: Comparative Frameworks and Operations. [PDF]
Pharmacy (Basel)Umaru OT +6 more
europepmc +1 more source
Value, development challenges, and strategies for gaining internal endorsement of digitally connected subcutaneous drug delivery devices: a survey of pharmaceutical stakeholders. [PDF]
Front Digit HealthSwick A +6 more
europepmc +1 more source
Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings. [PDF]
J Mark Access Health Policy, 2016 Sendyona S, Odeyemi I, Maman K.
europepmc +1 more source